North American Caviar Company in Paris was subject to a Food and Drug Administration (FDA) inspection on March 23, according to data posted on the FDA’s website.
The inspection addressed the following topics:
- Food Composition, Standards, Labeling and Econ
- Foodborne Biological Hazards
The final report found that North American Caviar Company did not need to take any corrective action regarding its management operations.
The FDA regularly inspects facilities throughout the U.S. to determine whether workplaces and products comply with FDA-regulated laws and regulations designed to promote public health. The results of these inspections are made publicly available.
According to its website, the FDA is a federal agency chiefly responsible for overseeing the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
